{
    "clinical_study": {
        "@rank": "3269", 
        "arm_group": [
            {
                "arm_group_label": "L-Tyrosine", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to investigate if treatment with L-Tyrosine improves selected\n      outcome measures of TNNT1 myopathy."
        }, 
        "brief_title": "Treatment of TNNT1-Myopathy With L-Tyrosine.", 
        "condition": "Nemaline Myopathy", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Diseases", 
                "Myopathies, Nemaline"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patients\n\n          -  any age with TNNT1-related myopathy\n\n        Exclusion Criteria:\n\n          -  Patients who are non-cooperative or parents/ legal guardians who are unwilling to\n             sign consent form"
            }, 
            "gender": "Both", 
            "maximum_age": "20 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035501", 
            "org_study_id": "SimonEdvardson1"
        }, 
        "intervention": [
            {
                "arm_group_label": "L-Tyrosine", 
                "intervention_name": "L-Tyrosine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Hadassah Medical Organization, Jerusalem, Israel"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "1. goal attainment score", 
            "safety_issue": "No", 
            "time_frame": "3 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035501"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hadassah Medical Organization", 
            "investigator_full_name": "Shimon Edverson", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}